Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Commitments and Contingencies (Details Narrative)

v3.21.1
Note 10 - Commitments and Contingencies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Research and development expense $ 1,640,000 $ 324,000
Research and Development Agreement    
Research and development expense $ 224,000